描述

Graphical representation of outcomes in a study of from metabolic dysregulation to neurodegenerative pathology, highlighting trends observed across experimental conditions.

More Figures from This Paper

Figure 1

Experimental results examining from metabolic dysregulation to neurodegenerative pathology, with data points illustrating key findings related to type 2 Diabetes (T2D) and Alzheimer's Disease (AD) share common risk factors that can be seen through T2D nearly doub.

chart

Figure 2

Statistical analysis from research investigating from metabolic dysregulation to neurodegenerative pathology, comparing treatment groups and control conditions.

chart

Figure 3

Measured parameters from a study evaluating from metabolic dysregulation to neurodegenerative pathology, contributing to the overall assessment of type 2 Diabetes (T2D) and Alzheimer's Disease (AD) share common risk factors that can be seen through T2D nearly doub.

chart

Figure 4

Chart

987 × 543px · 195.8 KB

Source Paper

From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer's disease.

Metabolic brain disease (2025)

PMID: 41003796

DOI: 10.1007/s11011-025-01700-z

Cite This Figure

![Figure 4: Graphical representation of outcomes in a study of from metabolic dysregulation to neurodegenerative pathology, highlighting trends observed across experimental conditions.](https://pdfs.citedhealth.com/figures/41003796/239.png)

> Source: Ahmad Raza et al. "From metabolic dysregulation to neurodegenerative pathology: the role of hypergl." *Metabolic brain disease*, 2025. PMID: [41003796](https://pubmed.ncbi.nlm.nih.gov/41003796/)

<figure>
  <img src="https://pdfs.citedhealth.com/figures/41003796/239.png" alt="Graphical representation of outcomes in a study of from metabolic dysregulation to neurodegenerative pathology, highlighting trends observed across experimental conditions." />
  <figcaption>Figure 4. Graphical representation of outcomes in a study of from metabolic dysregulation to neurodegenerative pathology, highlighting trends observed across experimental conditions.<br>  Source: Ahmad Raza et al. "From metabolic dysregulation to neurodegenerative pathology: the role of hypergl." <em>Metabolic brain disease</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/41003796/">41003796</a></figcaption>
</figure>

描述

More Figures from This Paper

Figure 4

Source Paper

Cite This Figure

相关证据